Acute Myelomonocytic Leukemia

Search Trials
Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML
Status:
Recruiting
Last Changed:
Feb 16, 2022
First Changed:
Oct 25, 2019
Disease(s):
AML/MDS
Intervention(s):
LP-108LP-108 and azacitidine
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose), With a Food Effect Substudy at Select Study Centers
Status:
Enrolling by invitation
Last Changed:
Dec 21, 2021
First Changed:
Sep 18, 2019
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
ASTX727
A Study of PRT1419 Injection in Patients With Relapsed/Refractory Hematologic Malignancies
Status:
Recruiting
Last Changed:
Apr 8, 2022
First Changed:
Nov 4, 2021
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
PRT1419
A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
Status:
Recruiting
Last Changed:
Apr 27, 2022
First Changed:
Jul 18, 2019
Disease(s):
Leukemia
Intervention(s):
CIML NKFludarabineCyclophosphamide

Connect. Empower. Inspire.